Cargando…
Enhanced Recovery after Surgery (ERAS) Program for Patients with Peritoneal Surface Malignancies Undergoing Cytoreductive Surgery with or without HIPEC: A Systematic Review and a Meta-Analysis
SIMPLE SUMMARY: Cytoreductive surgery and Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) represent a promising treatment strategy for the management of selected cases of peritoneal cancer, but it’s still burdened by significant morbidity and prolonged hospital stay. Herein, the review of the impa...
Autores principales: | Robella, Manuela, Tonello, Marco, Berchialla, Paola, Sciannameo, Veronica, Ilari Civit, Alba Maria, Sommariva, Antonio, Sassaroli, Cinzia, Di Giorgio, Andrea, Gelmini, Roberta, Ghirardi, Valentina, Roviello, Franco, Carboni, Fabio, Lippolis, Piero Vincenzo, Kusamura, Shigeki, Vaira, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913706/ https://www.ncbi.nlm.nih.gov/pubmed/36765534 http://dx.doi.org/10.3390/cancers15030570 |
Ejemplares similares
-
Laparoscopic Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Surface Malignancies (PSM): Italian PSM Oncoteam Evidence and Literature Review
por: Sommariva, Antonio, et al.
Publicado: (2022) -
Complications and Mortality Rate of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Italian Peritoneal Surface Malignancies Oncoteam Results Analysis
por: Carboni, Fabio, et al.
Publicado: (2022) -
Comments on: Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study
por: Batista, Thales Paulo, et al.
Publicado: (2019) -
Study Protocol: Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Metastases
por: Robella, Manuela, et al.
Publicado: (2021) -
Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes
por: Marrelli, Daniele, et al.
Publicado: (2022)